vTv Therapeutics (VTVT) Total Liabilities (2014 - 2026)
vTv Therapeutics (VTVT) posted Total Liabilities of $8.9 million for Q1 2026, down 65.23% sequentially from $25.5 million in Q4 2025, and down 61.72% YoY from $23.1 million in Q1 2025.
vTv Therapeutics (VTVT) Total Liabilities (2014 - 2026) Analysis & Trends
vTv Therapeutics has reported Total Liabilities for 13 years, with the latest figure at $8.9 million in Q1 2026.
- Quarterly Total Liabilities fell 61.72% year-over-year to $8.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.9 million (down 61.72% YoY) and the FY2025 annual result came in at $25.5 million, up 6.25% from the prior year.
- Total Liabilities slipped to $8.9 million in Q1 2026 per VTVT's latest filing, from $25.5 million in the prior quarter.
- Over five years, Total Liabilities peaked at $29.6 million in Q2 2022 and troughed at $8.9 million in Q1 2026.
- A 5-year average of $25.2 million and a median of $27.4 million in 2022 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2026: Total Liabilities soared 233.11% in 2022, then sank 61.72% in 2026.
- Over 5 years, Total Liabilities stood at $27.4 million in 2022, then climbed by 7.91% to $29.6 million in 2023, then decreased by 18.95% to $24.0 million in 2024, then grew by 6.25% to $25.5 million in 2025, then plunged by 65.23% to $8.9 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $8.9 million, $25.5 million, and $29.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | vTv Therapeutics | 373.77 Mn | 373.77 Mn | - | 8.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.96 Mn |
| Mar 31, 2026 | 8.85 Mn |
| Dec 31, 2025 | 25.46 Mn |
| Sep 30, 2025 | 28.95 Mn |
| Jun 30, 2025 | 24.04 Mn |
| Mar 31, 2025 | 23.13 Mn |
| Dec 31, 2024 | 23.97 Mn |
| Sep 30, 2024 | 25.25 Mn |
| Jun 30, 2024 | 26.02 Mn |
| Mar 31, 2024 | 28.20 Mn |
| Dec 31, 2023 | 29.57 Mn |
| Sep 30, 2023 | 29.44 Mn |
| Jun 30, 2023 | 28.83 Mn |
| Mar 31, 2023 | 28.42 Mn |
| Dec 31, 2022 | 27.40 Mn |
| Sep 30, 2022 | 27.88 Mn |
| Jun 30, 2022 | 29.60 Mn |
| Mar 31, 2022 | 13.91 Mn |
| Dec 31, 2021 | 10.25 Mn |
| Sep 30, 2021 | 8.37 Mn |